期刊文献+

膝骨性关节炎患者NO及TGF-β1与中医证型相关性临床研究 被引量:7

Clinical Study on Relativity of NO and TGF-Beta 1 Between Traditional Chinese Medicine Syndromes in Patients with Knee Osteoarthritis
下载PDF
导出
摘要 目的:探究膝骨性关节炎中医证型的临床表现和NO和TGF-β1之间的关系。方法:随机选取本院膝骨性关节炎患者60例,其中肾虚髓亏型患者30例为实验组1,瘀血阻滞型患者30例为实验组2。再选取30例健康人群为对照组。抽取实验组和对照组所有案例的血液,进行检测。实验组1和2治疗前后分别采血检测一氧化氮和转化生长因子-β1。对照组(3组)直接采血检测一氧化氮和生长转化因子-β1。分别比较1、2、3组在治疗前血液中的一氧化氮水平和转化生长因子-β1水平。结果:进行治疗之前,实验组1和实验组2血液中的一氧化氮含量远远高于对照组(3组)血液中的一氧化氮含量。实验1组和实验组2血液中转化生长因子-β1的含量又远远低于对照组(3组)血液中转化生长因子-β1的含量,且实验1组的血液中其含量高于实验组2血液中转化生长因子-β1的含量。三个小组两两比较,差异具有统计学意义P<0.05。治疗后,实验组的NO含量降低,且实验1组的血液中其含量低于实验组2血液中含量;转化生长因子-β1水平增高,且实验1组的血液中其含量高于实验组2,血液中含量差异具有统计学意义,P<0.05。结论:膝骨性关节炎的中医证型(肾虚髓亏、瘀血阻滞)与转化生长因子-β1及一氧化氮有一定相关性。 Objective: To investigate the clinical manifestation of TCM syndromes of knee osteoarthritis and the relationship between NO and TGF-β1. Methods: Sixty patients with knee osteoarthritis selected in our hospital,30 patients of marrow deficiency of kidney deficiency type were selected as experiment group 1,and 30 patients of stagnation of blood stasis type were selected as experimental study 2,and then 30 patients were diagnosed as healthy,as the controlled group of this experiment,as the third group. The blood of all cases in the experimental group and the controlled group was extracted and tested. In the experimental group,two groups of patients with the experiment group 1 and the experiment group 2 were treated for half a month respectively.The levels of nitric oxide and transforming growth factor-β1 were measured before and after treatment. The controlled group( group 3) was directly collected for the detection of nitric oxide and growth factor-β1. Results: Before treatment,the levels of nitric oxide in the blood of the two groups was much higher than that of the controlled group,the levels of transforming growth factor-β1 in the blood of the two groups were significantly lower than the controlled group( group 3),and the content of transforming growth factor-β1 in the blood of patients with deficiency of the experiment group 1 was higher than that of the experiment group 2.The difference was statistically significant P〈0. 05. After treatment,the NO content in the experimental group was decreased,and the content of the kidney in the blood group was lower than that in the patients with the experiment group 2. The level of transforming growth factor-beta 1 was increased,and the content of blood in the experimental group 1 was higher than that of the experimental group 2,the difference was statistically significant,P〈0. 05. Conclusion: Knee osteoarthritis syndrome and transforming growth factor-β1 and nitric oxide have a certain correlation.
出处 《四川中医》 2017年第8期54-56,共3页 Journal of Sichuan of Traditional Chinese Medicine
基金 北京市大兴区科学技术科研课题(编号:14060-2)
关键词 关节炎 中医证型 一氧化氮 生长因子 Arthritis TCM syndrome Nitric oxide Growth factor
  • 相关文献

参考文献11

二级参考文献162

  • 1孙永生,娄思权.骨性关节炎发病分子机制研究进展[J].中国骨与关节损伤杂志,2005,20(8):571-573. 被引量:54
  • 2邱贵兴.骨关节炎流行病学和病因学新进展[J].继续医学教育,2005,19(7):68-69. 被引量:177
  • 3杨大赋.中医辨证治疗类风湿性关节炎112例疗效观察[J].中医药临床杂志,2006,18(2):175-175. 被引量:10
  • 4Brereton N, Permington B, Ekelund M, et al. A cost-effectiveness analysis of celecoxib compared with diclofenac in the treatment of pain in osteoarthritis (OA) within the Swedish health system using an adaptation of the NICE OA model[J]. J Med Econ, 2014, 30:1-8.
  • 5Essex MN, Behar R, O'Connell MA, et al. Efficacy and tolerability of celecoxib and naproxen versus placebo in Hispanic patients with knee osteoarthritis[J]. Int J Gen Med, 2014, 16, 7:227-235.
  • 6Su SC, Tanimoto K, Tanne Y, et al. Celecoxib exerts protective effects on extracellular matrix metabolism of mandibular condylar chondrocytes under excessive mechanical stress [J]. Osteoarthritis Cartilage, 2014, 22(6): 845-851.
  • 7Yoo WH, Yoo HG, Park SH, et al. Efficacy and safety of PG201 and celecoxib in the treatment of symptomatic knee osteoarthritis: a double-blinded, randomized, multi-center, active drug comparative, parallel-group, non-inferiority, phase III study [J]. Rheumatol Int, 2014, 16 [Epub ahead of print].
  • 8Kellner HL, Li C, Essex MN. Celecoxib, Diclofenac and Omeprazole are Similarly Effective in the Treatment of Arthritis in Patients at High GI Risk in the CONDOR Trial[J]. Open Rheumatol J, 2013, 13, 7:96-100.
  • 9Conaghan PG, Bijlsma JW, Kneer W, et al. Drug-free gel containing ultra-deformable phospholipid vesicles (TDT 064) as topical therapy for the treatment of pain associated with osteoarthritis: a review of clinical efficacy and safety [J]. Curr Med Res Opin, 2014, 30(4): 599-611.
  • 10Hirayama A, Tanahashi N, Daida H, et al. Assessing the cardiovascular risk between eelecoxib and nonselective nonsteroidal antiinflammatory drugs in patients with rheumatoid arthritis and osteoarthritis[J]. Circ J, 2013, 78(1): 194-205.

共引文献446

同被引文献85

引证文献7

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部